tiprankstipranks
AstraZeneca PLC (GB:AZN)
LSE:AZN
UK Market
AZN
AstraZeneca
RESEARCH TOOLSreports
Want to see GB:AZN full AI Analyst Report?

AstraZeneca (AZN) Ratios

934 Followers

AstraZeneca Ratios

GB:AZN's free cash flow for Q1 2026 was $0.82. For the 2026 fiscal year, GB:AZN's free cash flow was decreased by $ and operating cash flow was $0.28. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 0.91 0.94 0.93 0.81 0.86
Quick Ratio
 0.71 0.72 0.74 0.64 0.68
Cash Ratio
 0.23 0.19 0.20 0.19 0.23
Solvency Ratio
 0.24 0.24 0.19 0.18 0.14
Operating Cash Flow Ratio
 0.44 0.48 0.43 0.34 0.37
Short-Term Operating Cash Flow Coverage
 1.88 4.70 5.50 2.11 1.88
Net Current Asset Value
$ -37.02B$ -36.63B$ -37.36B$ -37.11B$ -36.83B
Leverage Ratios
Debt-to-Assets Ratio
 0.30 0.26 0.29 0.28 0.30
Debt-to-Equity Ratio
 0.72 0.61 0.74 0.73 0.79
Debt-to-Capital Ratio
 0.42 0.38 0.42 0.42 0.44
Long-Term Debt-to-Capital Ratio
 0.34 0.34 0.39 0.36 0.38
Financial Leverage Ratio
 2.41 2.34 2.55 2.58 2.61
Debt Service Coverage Ratio
 1.95 3.68 3.76 2.02 1.54
Interest Coverage Ratio
 8.54 8.11 9.19 8.31 5.69
Debt to Market Cap
 0.11 0.10 0.14 0.13 0.13
Interest Debt Per Share
 22.98 20.20 20.31 18.92 19.40
Net Debt to EBITDA
 1.28 1.21 1.66 1.71 2.66
Profitability Margins
Gross Profit Margin
79.71%81.90%74.98%73.95%63.36%
EBIT Margin
24.14%24.00%18.70%17.56%7.65%
EBITDA Margin
33.76%33.76%28.06%28.33%19.50%
Operating Profit Margin
23.53%23.40%23.65%20.54%11.41%
Pretax Profit Margin
21.37%21.11%16.07%15.06%5.64%
Net Profit Margin
17.19%17.41%13.01%13.00%7.41%
Continuous Operations Profit Margin
17.19%17.42%13.02%13.01%7.42%
Net Income Per EBT
80.43%82.45%80.95%86.32%131.47%
EBT Per EBIT
90.81%90.24%67.96%73.31%49.43%
Return on Assets (ROA)
9.17%8.96%6.62%5.99%3.40%
Return on Equity (ROE)
22.41%21.01%16.89%15.47%8.86%
Return on Capital Employed (ROCE)
17.57%16.47%16.44%13.56%7.19%
Return on Invested Capital (ROIC)
12.88%13.04%12.90%10.94%6.67%
Return on Tangible Assets
18.70%18.60%15.03%14.09%8.78%
Earnings Yield
3.67%3.56%3.39%2.87%1.56%
Efficiency Ratios
Receivables Turnover
 4.31 3.59 4.05 3.94 4.81
Payables Turnover
 0.55 0.42 3.64 3.71 6.36
Inventory Turnover
 1.88 1.62 2.51 2.26 3.45
Fixed Asset Turnover
 4.07 4.00 4.55 4.44 4.68
Asset Turnover
 0.53 0.51 0.51 0.46 0.46
Working Capital Turnover Ratio
 -25.08 -29.67 -13.64 -9.91 -563.30
Cash Conversion Cycle
 -386.58 -541.16 135.45 156.22 124.19
Days of Sales Outstanding
 84.65 101.54 90.18 92.72 75.82
Days of Inventory Outstanding
 194.29 225.08 145.57 161.76 105.79
Days of Payables Outstanding
 665.51 867.79 100.31 98.26 57.41
Operating Cycle
 278.93 326.62 235.75 254.49 181.60
Cash Flow Ratios
Operating Cash Flow Per Share
 9.18 9.40 7.65 6.62 6.34
Free Cash Flow Per Share
 5.67 5.59 4.69 4.20 4.68
CapEx Per Share
 3.51 3.81 2.96 2.42 1.66
Free Cash Flow to Operating Cash Flow
 0.62 0.59 0.61 0.63 0.74
Dividend Paid and CapEx Coverage Ratio
 1.37 1.34 1.29 1.25 1.41
Capital Expenditure Coverage Ratio
 2.62 2.47 2.59 2.74 3.81
Operating Cash Flow Coverage Ratio
 0.42 0.49 0.39 0.36 0.34
Operating Cash Flow to Sales Ratio
 0.23 0.25 0.22 0.22 0.22
Free Cash Flow Yield
3.08%3.01%3.58%3.12%3.45%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 27.18 28.13 29.47 34.81 63.97
Price-to-Sales (P/S) Ratio
 4.68 4.90 3.83 4.52 4.74
Price-to-Book (P/B) Ratio
 6.00 5.91 4.98 5.38 5.67
Price-to-Free Cash Flow (P/FCF) Ratio
 32.37 33.17 27.90 32.10 29.00
Price-to-Operating Cash Flow Ratio
 19.98 19.73 17.11 20.37 21.40
Price-to-Earnings Growth (PEG) Ratio
 0.83 0.58 2.17 0.41 0.02
Price-to-Fair Value
 6.00 5.91 4.98 5.38 5.67
Enterprise Value Multiple
 15.13 15.71 15.32 17.69 26.98
Enterprise Value
 311.32B 311.51B 227.63B 233.39B 232.85B
EV to EBITDA
 15.16 15.71 15.32 17.69 26.98
EV to Sales
 5.12 5.30 4.30 5.01 5.26
EV to Free Cash Flow
 35.43 35.93 31.29 35.54 32.18
EV to Operating Cash Flow
 21.89 21.37 19.19 22.56 23.74
Tangible Book Value Per Share
 -6.92 -6.69 -11.18 -12.04 -14.26
Shareholders’ Equity Per Share
 30.56 31.40 26.31 25.06 23.93
Tax and Other Ratios
Effective Tax Rate
 0.20 0.17 0.19 0.14 -0.32
Revenue Per Share
 39.27 37.90 34.16 29.82 28.59
Net Income Per Share
 6.75 6.60 4.44 3.88 2.12
Tax Burden
 0.80 0.82 0.81 0.86 1.31
Interest Burden
 0.89 0.88 0.86 0.86 0.74
Research & Development to Revenue
 0.24 0.24 0.23 0.23 0.22
SG&A to Revenue
 0.33 0.35 0.29 0.00 0.00
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.01 0.01
Income Quality
 1.17 1.18 1.36 1.50 3.92
Currency in USD